Fiche publication
Date publication
mai 2020
Journal
Journal of Crohn's & colitis
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
D'Amico F, Nancey S, Danese S, Peyrin-Biroulet L
Lien Pubmed
Résumé
Faecal calprotectin (FC) is a valid and non-invasive marker of mucosal inflammation. It is widely used both in clinical trials and daily clinical practice for patients with inflammatory bowel diseases but currently no accepted standardization for FC testing is available. The primary aim of our work was to provide a clinician's guide containing all the practical information on FC measurement in order to avoid any confounding factors, to minimize intra and inter-individual variability of the dosage, and to ensure a better and adequate interpretation of its result.
Mots clés
faecal calprotectin, guide, inflammatory bowel disease
Référence
J Crohns Colitis. 2020 May 11;:
